España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
GoodRx Holdings
GDRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.71
0.00
0.00%
Pre-Market: 4:41 PM EDT
Get Report
Comment
GoodRx Holdings (GDRX) Forecast
News
Earnings
GoodRx Holdings (GDRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for GoodRx Holdings (NASDAQ:GDRX) Stock
GoodRx Holdings Stock (NASDAQ: GDRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 10, 2025
Citigroup Maintains Buy on GoodRx Holdings, L...
Benzinga Newsdesk
Wednesday, January 08, 2025
Assessing GoodRx Holdings: Insights From 4 Financial Analysts
Benzinga Insights
Keybanc Maintains Overweight on GoodRx Holdin...
Benzinga Newsdesk
Tuesday, December 17, 2024
Morgan Stanley Maintains Equal-Weight on Good...
Benzinga Newsdesk
Monday, December 16, 2024
GoodRx Appoints Wendy Barnes As New Chief Exe...
Benzinga Newsdesk
Thursday, December 12, 2024
Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel
Vandana Singh
Thursday, December 05, 2024
How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals
Vandana Singh
Wednesday, November 13, 2024
Citigroup Maintains Buy on GoodRx Holdings, L...
Benzinga Newsdesk
Harrow Announced An Innovative Initiative To ...
Benzinga Newsdesk
Monday, November 11, 2024
Barclays Maintains Overweight on GoodRx Holdi...
Benzinga Newsdesk
Thursday, November 07, 2024
GoodRx Holdings shares are trading lower afte...
Benzinga Newsdesk
GoodRx Expects 2024 Sales Of Around $794M Vs....
Benzinga Newsdesk
GoodRx Expects Q4 2024 Sales Of Around $200M ...
Benzinga Newsdesk
GoodRx Holdings Q3 2024 Adj EPS $0.08 Misses ...
Benzinga Newsdesk
Tuesday, October 29, 2024
Anyone With A Valid Prescription, Regardless ...
Benzinga Newsdesk
GoodRx Announces Exclusive Low Cash Price For...
Benzinga Newsdesk
Wednesday, October 16, 2024
GoodRx Partners With Retail Pharmacies, Inclu...
Benzinga Newsdesk
Friday, September 27, 2024
Shares of pharmacy stocks are trading higher....
Benzinga Newsdesk
Thursday, September 26, 2024
GoodRx Announces Lowest Discounted Cash Price...
Benzinga Newsdesk
Tuesday, August 27, 2024
GoodRx Holdings shares are trading higher pos...
Benzinga Newsdesk
Friday, August 16, 2024
GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Benzinga Insights
RBC Capital Reiterates Outperform on GoodRx H...
Benzinga Newsdesk
Friday, August 09, 2024
Citigroup Maintains Buy on GoodRx Holdings, L...
Benzinga Newsdesk
UBS Maintains Neutral on GoodRx Holdings, Low...
Benzinga Newsdesk
Thursday, August 08, 2024
GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges
Vandana Singh
GoodRx Holdings shares are trading lower afte...
Benzinga Newsdesk
GoodRx FY24 Revenue Outlook Lower End Of Prev...
Benzinga Newsdesk
GoodRx Q3 Revenue Outlook $193M-$197M Vs, $20...
Benzinga Newsdesk
GoodRx Holdings Q2 2024 Adj. EPS $0.08 Misses...
Benzinga Newsdesk
Thursday, July 18, 2024
Boehringer Ingelheim and GoodRx Team Up to Of...
Benzinga Newsdesk
Monday, July 15, 2024
MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Wednesday, June 26, 2024
GoodRx Debuts Prescription Cost Tracker; Aims...
Benzinga Newsdesk
Monday, June 10, 2024
The Analyst Landscape: 7 Takes On GoodRx Holdings
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Good...
Benzinga Newsdesk
Thursday, May 23, 2024
GoodRx Strengthens Core Business With New Initiatives, Analyst Upgrades On Potential Opportunities
Vandana Singh
GoodRx Holdings shares are trading higher aft...
Benzinga Newsdesk
RBC Capital Upgrades GoodRx Holdings to Outpe...
Benzinga Newsdesk
Monday, May 20, 2024
Barclays Maintains Overweight on GoodRx Holdi...
Benzinga Newsdesk
Friday, May 17, 2024
GoodRx shares are trading lower, pulling back...
Benzinga Newsdesk
Thursday, May 16, 2024
Raymond James Upgrades GoodRx Holdings to Out...
Benzinga Newsdesk
GoodRx Holdings shares are trading higher aft...
Benzinga Newsdesk
Forecasting The Future: 13 Analyst Projections For GoodRx Holdings
Benzinga Insights
TD Cowen Maintains Buy on GoodRx Holdings, Ra...
Benzinga Newsdesk
Wednesday, May 15, 2024
GoodRx Shares Soar Nearly 10% As New Partnership With Kroger Promises Big Savings
Vaishali Prayag
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
GoodRx Holdings shares are trading higher aft...
Benzinga Newsdesk
GoodRx Announced A New Direct Contracting Agr...
Benzinga Newsdesk
Thursday, May 09, 2024
Change Healthcare Cyberattack: GoodRx Expects Low Single Digit Million-Dollar Impact In 2024
Vandana Singh
GoodRx shares are trading lower after the com...
Benzinga Newsdesk
GoodRx Forecasts 2024 Revenue Of $800M-$810M ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
